Medixine
Finnish remote monitoring suite that pairs a Bluetooth hub app with triage lists, questionnaires and video visits
Quick Overview
| Company | Medixine Ltd. |
|---|---|
| Category | Remote Patient Monitoring Software |
| Headquarters | Espoo, Finland |
| Founded | 2000 |
| EU Presence | Yes - Finland (EU) |
| Data Location | Not stated on the pages reviewed |
| Open Source | No |
| GDPR Compliant | Yes |
| Self-Hosting | Not stated |
| Main Features | Remote vital-sign monitoring, limit and flagging rules, triage and screening lists, health questionnaires, video consultations, secure messaging, Android hub app, open APIs, white label |
| Pricing | Pricing on request |
| Best For | Care providers and device partners who want a configurable, white-label monitoring layer |
| Replaces | Biofourmis, Current Health, other US remote monitoring suites |
Detailed Review
Medixine was founded in 2000 by a physician and spent its first fifteen years as a digital-health consultancy before releasing Medixine Suite in 2015. That history shows in the product: it is a configurable toolkit more than a fixed care programme.
The company describes a team of 25 people and customers in Europe and the United States. Its footer gives an Espoo address and a Finnish business ID, which is the contracting entity a European buyer would sign with.
A Hub App Instead of a Patient Phone
Measurement kits contain a hub device and Bluetooth instruments. The Medixine Hub Android app forwards each reading to the platform, so the patient only keeps the device on and measures as instructed.
The device list on the product page names blood pressure cuffs, a pulse oximeter, spirometers, a Bittium ECG recorder and body scales, which makes it a hardware-agnostic option.
Flagging Rules and a Prioritised List
Limits can be population-wide or personal, and absolute or relative. Readings outside them feed an automatic list of patients who need attention, which can be shared and assigned inside the care team.
Certified Software, White Label Allowed
The vendor states that Medixine Suite is a class IIa medical device under the EU MDR and that its quality system follows EN ISO 13485:2016. Partners can embed the functions in their own portfolio through open APIs.
Limitations to Consider
Medixine publishes no price and no hosting location on the pages we reviewed, so both need to be requested. The patient side is an Android hub app, which matters if your population uses other devices. Compared with Luscii it has no ready-made library of disease programmes that we could verify.
Who Should Use Medixine
Healthcare operators, device makers and telehealth providers who need a monitoring platform they can brand and configure themselves.
Pros and Cons
Pros
- EU MDR class IIa certificate stated by the vendor
- Wide device list across vitals, ECG and spirometry
- Personal and population-wide alert limits
- White label and open APIs
- Questionnaires, video and messaging in the same suite
Cons
- No public pricing
- Patient hub app is Android
- Hosting location not stated
- Small team of about 25
Alternatives to Medixine
Other European remote patient monitoring software worth comparing before you decide:
Healthentia
Belgium · Class IIa software for monitoring, coaching and trial data
Cuviva
Sweden · White-label platform with Swedish storage options
Luscii
Netherlands · Home monitoring programmes for 150+ conditions
Corsano Health
Netherlands · Medical wristband with cloud and raw data access
See all European remote patient monitoring software or compare them directly against Biofourmis on our alternatives page.
Frequently Asked Questions
The product page lists glucose meters, A&D and Omron blood pressure monitors, thermometers, Nonin and Beurer pulse oximeters, a Bittium Faros ECG recorder, Vitalograph spirometers, weight scales and Garmin or Beurer activity trackers.
Yes. The company says all functions integrate into an existing portfolio, can be white-labelled and are configurable through open APIs.
The vendor states that Medixine Suite carries a CE mark as a class IIa device under EU MDR 2017/745, and that the company is certified to EN ISO 13485:2016.